|
| U.S. Brand
Names |
|
| AK-Spore® Ophthalmic Ointment;
Medi-Quick® Topical Ointment [OTC]; Mycitracin® Topical [OTC];
Neomixin® Topical [OTC]; Neosporin® Ophthalmic Ointment;
Neosporin® Topical Ointment [OTC]; Ocutricin® Topical
Ointment; Septa® Topical Ointment [OTC]; Triple Antibiotic®
Topical |

|
|
| Generic
Available |
|
|
Yes |

|
|
| Canadian Brand
Names |
|
| Neotopic |

|
|
| Synonyms |
|
|
Neomycin, Bacitracin, and Polymyxin B; Polymyxin B, Bacitracin, and
Neomycin |

|
|
| Pharmacological Index |
|
|
Antibiotic, Ophthalmic; Antibiotic, Topical |

|
|
| Use |
|
|
Helps prevent infection in minor cuts, scrapes and burns; short-term
treatment of superficial external ocular infections caused by susceptible
organisms |

|
|
| Pregnancy Risk
Factor |
|
|
C |

|
|
| Contraindications |
|
|
Hypersensitivity to neomycin, polymyxin B, or zinc bacitracin; epithelial
herpes simplex keratitis; mycobacterial or fungal infections; topical ointments
for external use only |

|
|
| Adverse
Reactions |
|
|
1% to 10%:
Dermatologic: Reddening, allergic contact dermatitis
Local: Itching, failure to heal |

|
|
| Drug
Interactions |
|
|
No data reported |

|
|
| Mechanism of
Action |
|
|
Refer to individual monographs for Bacitracin; Neomycin Sulfate; and
Polymyxin B Sulfate |

|
|
| Usual Dosage |
|
|
Children and Adults:
Topical: Apply 1-5 times/day to infected area and cover with sterile bandage
as needed |

|
|
| Mental Health: Effects
on Mental Status |
|
|
None reported |

|
|
| Mental Health:
Effects on Psychiatric
Treatment |
|
|
None reported |

|
|
| Dental Health: Local
Anesthetic/Vasoconstrictor
Precautions |
|
|
No information available to require special precautions |

|
|
| Dental Health:
Effects on Dental Treatment |
|
|
No effects or complications reported |

|
|
| Patient
Information |
|
|
See individual agents. Pregnancy/breast-feeding precautions: Inform
prescriber if you are or intend to be pregnant. Consult prescriber if
breast-feeding. |

|
|
| Nursing
Implications |
|
|
Symptoms of neomycin sensitization include itching, reddening, edema, failure
to heal; ophthalmic ointments may retard corneal healing |

|
|
| Dosage Forms |
|
|
Ointment:
Topical: Bacitracin 400 units, neomycin sulfate 3.5 mg, and polymyxin B
sulfate 5000 units per g |

|
|
Copyright © 2007 Drugs Area
|